3004 Hongmei Fu et al. Eur. J. Immunol. 2011. 41: 2997–3005 3 Barker, C. F. and Billingham, R. E., Immunologically privileged sites. Adv. Immunol. 1977. 25: 1–54. 4 Grifﬁth, T. S., Brunner, T., Fletcher, S. M., Green, D. R. and Ferguson, T. A., Fas ligand-induced apoptosis as a mechanism of immune privilege. Science 1995. 270: 1189–1192. 5 Streilein, J. W., Toews, G. B. and Bergstresser, P. R., Corneal allografts fail to express Ia antigens. Nature 1979. 282: 326–327. 6 Wang, H. M., Kaplan, H. J., Chan, W. C. and Johnson, M., The distribution and ontogeny of MHC antigens in murine ocular tissue. Invest. Ophthalmol. Vis. Sci. 1987. 28: 1383–1389. 7 Forrester, J. V., Xu, H., Kuffova, L., Dick, A. D. and McMenamin, P. G., Dendritic cell physiology and function in the eye. Immunol. Rev. 2010. 234: 282–304. 8 Stein-Streilein, J. and Streilein, J. W., Anterior chamber associated immune deviation (ACAID): regulation, biological relevance, and implica- tions for therapy. Int. Rev. Immunol. 2002. 21: 123–152. 9 Niederkorn, J. Y. and Larkin, D. F., Immune privilege of corneal allografts. Ocul. Immunol. Inﬂamm. 2010. 18: 162–171. 10 Bernard, A. C., Mistry, S. K., Morris, S. M., Jr., O’Brien, W. E., Tsuei, B. J., Maley, M. E., Shirley, L. A. et al., Alterations in arginine metabolic enzymes in trauma. Shock 2001. 15: 215–219. 11 Wu, G. and Morris, S. M., Jr., Arginine metabolism: nitric oxide and beyond. Biochem. J. 1998. 336: 1–17. 12 Hibbs, J. B., Jr., Taintor, R. R. and Vavrin, Z., Macrophage cytotoxicity: role for L-arginine deiminase and imino nitrogen oxidation to nitrite. Science 1987. 235: 473–476. 13 Jenkinson, C. P., Grody, W. W. and Cederbaum, S. D., Comparative properties of arginases. Comp. Biochem. Physiol. B Biochem. Mol. Biol. 1996. 114: 107–132. 14 Rodriguez, P. C., Quiceno, D. G., Zabaleta, J., Ortiz, B., Zea, A. H., Piazuelo, M. B., Delgado, A. et al., Arginase I production in the tumor microenvir- onment by mature myeloid cells inhibits T-cell receptor expression and antigen-speciﬁc T-cell responses. Cancer Res. 2004. 64: 5839–5849. 15 Rodriguez, P. C., Ernstoff, M. S., Hernandez, C., Atkins, M., Zabaleta, J., Sierra, R. and Ochoa, A. C., Arginase I-producing myeloid-derived suppressor cells in renal cell carcinoma are a subpopulation of activated granulocytes. Cancer Res. 2009. 69: 1553–1560. 16 Munder, M., Schneider, H., Luckner, C., Giese, T., Langhans, C. D., Fuentes, J. M., Kropf, P. et al., Suppression of T-cell functions by human granulocyte arginase. Blood 2006. 108: 1627–1634. 17 Kropf, P., Baud, D., Marshall, S. E., Munder, M., Mosley, A., Fuentes, J. M., Bangham, C. R. et al., Arginase activity mediates reversible T cell hyporesponsiveness in human pregnancy. Eur. J. Immunol. 2007. 37: 935–945. 18 Munder, M., Eichmann, K. and Modolell, M., Alternative metabolic states in murine macrophages reﬂected by the nitric oxide synthase/arginase balance: competitive regulation by CD41 T cells correlates with Th1/Th2 phenotype. J. Immunol. 1998. 160: 5347–5354. 19 Iyer, R. K., Yoo, P. K., Kern, R. M., Rozengurt, N., Tsoa, R., O’Brien, W. E., Yu, H. et al., Mouse model for human arginase deﬁciency. Mol. Cell. Biol. 2002. 22: 4491–4498. 20 Jeyabalan, G., Klune, J. R., Nakao, A., Martik, N., Wu, G., Tsung, A. and Geller, D. A., Arginase blockade protects against hepatic damage in warm ischemia-reperfusion. Nitric Oxide 2008. 19: 29–35. 21 King, W. J., Comer, R. M., Hudde, T., Larkin, D. F. and George, A. J., Cytokine and chemokine expression kinetics after corneal transplanta- tion. Transplantation 2000. 70: 1225–1233. 22 Sagoo, P., Chan, G., Larkin, D. F. and George, A. J., Inﬂammatory cytokines induce apoptosis of corneal endothelium through nitric oxide. Invest. Ophthalmol. Vis. Sci. 2004. 45: 3964–3973. 23 Bradley, B. A., Vail, A., Gore, S. M., Rogers, C. A., Armitage, W. J., Nicholls, S. M. and Easty, D. L., Penetrating keratoplasty in the United Kingdom: an interim analysis of the corneal transplant follow-up study. Clin. Trans- plant. 1993. 293–315. 24 Hooper, P., Bora, N. S., Kaplan, H. J. and Ferguson, T. A., Inhibition of lymphocyte proliferation by resident ocular cells. Curr. Eye Res. 1991. 10: 363–372. 25 Wilbanks, G. A. and Streilein, J. W., Fluids from immune privileged sites endow macrophages with the capacity to induce antigen-speciﬁc immune deviation via a mechanism involving transforming growth factor-beta. Eur. J. Immunol. 1992. 22: 1031–1036. 26 Yu, H., Yoo, P. K., Aguirre, C. C., Tsoa, R. W., Kern, R. M., Grody, W. W., Cederbaum, S. D. and Iyer, R. K., Widespread expression of arginase I in mouse tissues. Biochemical and physiological implications. J. Histochem. Cytochem. 2003. 51: 1151–1160. 27 Rodriguez, P. C., Zea, A. H., Culotta, K. S., Zabaleta, J., Ochoa, J. B. and Ochoa, A. C., Regulation of T cell receptor CD3zeta chain expression by L-arginine. J. Biol. Chem. 2002. 277: 21123–21129. 28 Mistry, S. K., Zheng, M., Rouse, B. T. and Morris, S. M., Jr., Induction of arginases I and II in cornea during herpes simplex virus infection. Virus Res. 2001. 73: 177–182. 29 Holan, V., Pindjakova, J., Krulova, M., Neuwirth, A., Fric, J. and Zajicova, A., Production of nitric oxide during graft rejection is regulated by the Th1/Th2 balance, the arginase activity, and L-arginine metabolism. Transplantation 2006. 81: 1708–1715. 30 Debats, I. B., Wolfs, T. G., Gotoh, T., Cleutjens, J. P., Peutz-Kootstra, C. J. and van der Hulst, R. R., Role of arginine in superﬁcial wound healing in man. Nitric Oxide 2009. 21: 175–183. 31 Sugioka, A., Morita, M., Fujita, J., Hasumi, A. and Shiroishi, T., Graft acceptance and tolerance induction in mouse liver transplantation using wild mice. Transplant. Proc. 2001. 33: 137–139. 32 Qian, S., Demetris, A. J., Murase, N., Rao, A. S., Fung, J. J. and Starzl, T. E., Murine liver allograft transplantation: tolerance and donor cell chimer- ism. Hepatology 1994. 19: 916–924. 33 Chicoine, L. G., Paffett, M. L., Young, T. L. and Nelin, L. D., Arginase inhibition increases nitric oxide production in bovine pulmonary arterial endothelial cells. Am. J. Physiol. Lung Cell Mol. Physiol. 2004. 287: L60–L68. 34 Li, H., Meininger, C. J., Hawker, J. R., Jr., Haynes, T. E., Kepka-Lenhart, D., Mistry, S. K., Morris, S. M., Jr. and Wu, G., Regulatory role of arginase I and II in nitric oxide, polyamine, and proline syntheses in endothelial cells. Am. J. Physiol. Endocrinol. Metab. 2001. 280: E75–E82. 35 Fligger, J., Blum, J. and Jungi, T. W., Induction of intracellular arginase activity does not diminish the capacity of macrophages to produce nitric oxide in vitro. Immunobiology 1999. 200: 169–186. 36 Cobbold, S. P., Adams, E., Farquhar, C. A., Nolan, K. F., Howie, D., Lui, K. O., Fairchild, P. J. et al., Infectious tolerance via the consumption of essential amino acids and mTOR signaling. Proc. Natl. Acad. Sci. USA 2009. 106: 12055–12060. 37 Mellor, A. L. and Munn, D. H., IDO expression by dendritic cells: tolerance and tryptophan catabolism. Nat. Rev. Immunol. 2004. 4: 762–774. 38 Munn, D. H., Zhou, M., Attwood, J. T., Bondarev, I., Conway, S. J., Marshall, B., Brown, C. and Mellor, A. L., Prevention of allogeneic fetal rejection by tryptophan catabolism. Science 1998. 281: 1191–1193. & 2011 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim www.eji-journal.eu